Variables associated with antibiotic treatment tolerance in patients with Mycobacterium avium complex pulmonary disease.

"Declarations Ethics approval and consent to participatesThis study protocol was approved indefinitely by the Stanford Institutional Review Board (IRB. -60666) on April 26, 2021. In accordance with data protection regulations, individual patient consent was waved as this retrospective chart review posed little to no harm to patients. Institutional Review BoardThis study was approved by Stanford’s Institutional Review Board. None of the authors have any competing interests to declare. Data and materials are property of Stanford Health Care electronic medical record and are not available for outside review. This study was not funded. Marmor is the primary author and responsible for data collection. Sharifi contributed to data collection and was the primary data analyst. Jacobs contributed to data interpretation and writing of the manuscript. Fazeli contributed to manuscript writing. Ruoss contributed to data interpretation and manuscript writing. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This study was not funded."